Article
Peginterferon Alfa-2a plus ribavirin in Japanese patients infected with hepatitis C virus genotype 2 who failed previous interferon therapy.
International journal of medical sciences - 1 Jan 2013
Kanda Tatsuo, Nakamoto Shingo, Nishino Takayoshi, Takada Nobuo, Tsubota Akihito, Kato Keizo, Miyamura Tatsuo, Maruoka Daisuke, Wu Shuang, Tanaka Takeshi, Arai Makoto, Mikami Shigeru, Fujiwara Keiichi, Imazeki Fumio, Yokosuka Osamu
Abstract excerpt
Some patients infected with hepatitis C virus (HCV) genotype 2 could be cured with treatment shorter than 24 weeks using peginterferon plus ribavirin, but there are still treatment-refractory patients. Direct-acting antivirals (DAAs) are not currently available for HCV genotype 2 patients, different from genotype 1 patients, in clinical practice. We investigated 29 HCV genotype 2-infected Japanese patients who...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.